KNSA · CIK 0001730430 · operating
Kiniksa Pharmaceuticals International, plc (KNSA) is a pharmaceutical preparations company, listed on the Nasdaq. With a market capitalization of $3.5 billion, Kiniksa Pharmaceuticals International, plc is a mid-cap company. The stock currently trades at $45.30, down 1.52% today, with a 52-week range of $18.25–$49.12. The company trades at a trailing P/E of 102.2x and a forward P/E of 26.8x.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $0.75 | $0.80 | +225.0% | |
| 2024 | $-0.60 | $-0.60 | -400.0% | |
| 2023 | $0.20 | $0.20 | -92.3% | |
| 2022 | $2.60 | $2.64 | +213.0% | |
| 2021 | $-2.30 | $-2.30 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-24 | 0001104659-26-019168 | SEC ↗ |
| 2024-12-31 | 2025-02-25 | 0001558370-25-001505 | SEC ↗ |
| 2023-12-31 | 2024-02-28 | 0001558370-24-002005 | SEC ↗ |
| 2022-12-31 | 2023-03-02 | 0001558370-23-002684 | SEC ↗ |
| 2021-12-31 | 2022-02-24 | 0001558370-22-001932 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001558370-21-001821 | SEC ↗ |
| 2019-12-31 | 2020-03-05 | 0001558370-20-002081 | SEC ↗ |
| 2018-12-31 | 2019-03-12 | 0001558370-19-001857 | SEC ↗ |